6.91
price down icon10.49%   -0.81
after-market Dopo l'orario di chiusura: 7.04 0.13 +1.88%
loading
Precedente Chiudi:
$7.72
Aprire:
$7.7
Volume 24 ore:
1.45M
Relative Volume:
4.14
Capitalizzazione di mercato:
$408.20M
Reddito:
-
Utile/perdita netta:
$-153.16M
Rapporto P/E:
-1.8726
EPS:
-3.69
Flusso di cassa netto:
$-134.48M
1 W Prestazione:
-9.20%
1M Prestazione:
-12.97%
6M Prestazione:
-15.01%
1 anno Prestazione:
-63.01%
Intervallo 1D:
Value
$6.61
$7.70
Intervallo di 1 settimana:
Value
$6.61
$7.82
Portata 52W:
Value
$6.61
$19.66

Cullinan Therapeutics Inc Stock (CGEM) Company Profile

Name
Nome
Cullinan Therapeutics Inc
Name
Telefono
617-410-4650
Name
Indirizzo
ONE MAIN STREET, CAMBRIDGE
Name
Dipendente
111
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
CGEM's Discussions on Twitter

Confronta CGEM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CGEM
Cullinan Therapeutics Inc
6.91 442.47M 0 -153.16M -134.48M -3.69
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Cullinan Therapeutics Inc Stock (CGEM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-08-21 Ripresa H.C. Wainwright Buy
2025-06-11 Ripresa Stifel Buy
2024-10-24 Iniziato UBS Buy
2024-05-01 Iniziato Stifel Buy
2024-04-15 Iniziato William Blair Outperform
2024-02-15 Iniziato Wedbush Outperform
2023-06-15 Iniziato TD Cowen Outperform
2022-11-21 Iniziato BTIG Research Buy
2021-04-27 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2021-02-02 Iniziato Evercore ISI Outperform
2021-02-02 Iniziato Morgan Stanley Equal-Weight
2021-02-02 Iniziato SVB Leerink Outperform
2021-02-01 Iniziato H.C. Wainwright Buy
Mostra tutto

Cullinan Therapeutics Inc Borsa (CGEM) Ultime notizie

pulisher
Sep 03, 2025

Is Cullinan Therapeutics Inc. stock trending bullishWeekly Trading Summary & AI Driven Stock Movement Reports - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Analyzing drawdowns of Cullinan Therapeutics Inc. with statistical toolsPortfolio Growth Summary & Long-Term Growth Stock Strategies - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What institutional flow reveals about Cullinan Therapeutics Inc.July 2025 Action & Weekly Setup with High ROI Potential - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Chart based analysis of Cullinan Therapeutics Inc. trendsEarnings Beat & High Conviction Buy Zone Picks - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to use Fibonacci retracement on Cullinan Therapeutics Inc.2025 Market Outlook & Fast Entry and Exit Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Live market analysis of Cullinan Therapeutics Inc.Quarterly Profit Review & Free Expert Approved Momentum Trade Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Real time scanner hits for Cullinan Therapeutics Inc. explainedPortfolio Gains Report & Daily Technical Forecast Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Order flow analysis tools used on Cullinan Therapeutics Inc.New Guidance & Safe Entry Trade Reports - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Is this a good reentry point in Cullinan Therapeutics Inc.Bond Market & Weekly High Potential Stock Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Cullinan Therapeutics Inc. meeting your algorithmic filter criteria2025 Volume Leaders & Long-Term Growth Stock Strategies - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Will Cullinan Therapeutics Inc. benefit from government policyMarket Movement Recap & Long-Term Safe Investment Plans - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Can Cullinan Therapeutics Inc. hit a new high this monthJuly 2025 Weekly Recap & Stock Portfolio Risk Control - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Real time alert setup for Cullinan Therapeutics Inc. performanceWeekly Trade Analysis & Verified Trade Idea Suggestions - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What the charts say about Cullinan Therapeutics Inc. today2025 Earnings Surprises & Daily Technical Stock Forecast Reports - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Short Interest Drops in Cullinan Therapeutics Inc. After RallyProfit Target & Consistent Profit Trade Alerts - beatles.ru

Sep 02, 2025
pulisher
Sep 02, 2025

Chart overlay techniques for tracking Cullinan Therapeutics Inc.Bear Alert & Technical Analysis for Trade Confirmation - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Update Recap: Why is Cullinan Therapeutics Inc. stock going upJuly 2025 Breakouts & Free Real-Time Market Sentiment Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 01, 2025

Pattern recognition hints at Cullinan Therapeutics Inc. upsideWeekly Trading Summary & Expert Verified Movement Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Measuring Cullinan Therapeutics Inc.’s beta against major indicesMarket Performance Summary & Fast Exit and Entry Trade Guides - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Fibonacci Retracement Aligns with Support in Cullinan Therapeutics Inc.July 2025 Movers & AI Forecast Swing Trade Picks - beatles.ru

Sep 01, 2025
pulisher
Sep 01, 2025

What Technical Tools Say About Cullinan Therapeutics Inc. Recovery getLinesFromResByArray error: size == 0 - kangso.co.kr

Sep 01, 2025
pulisher
Sep 01, 2025

Is now the right time to enter Cullinan Therapeutics Inc.July 2025 Gainers & Weekly Consistent Profit Watchlists - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Is Cullinan Therapeutics Inc. on track to beat earningsPortfolio Profit Report & Low Risk Entry Point Guides - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Is Cullinan Therapeutics Inc. showing signs of accumulationJuly 2025 Movers & Smart Allocation Stock Reports - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Is it too late to sell Cullinan Therapeutics Inc.2025 Earnings Impact & Consistent Return Investment Signals - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Analyzing net buyer seller activity in Cullinan Therapeutics Inc.July 2025 PostEarnings & Verified Short-Term Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Using AI based signals to follow Cullinan Therapeutics Inc.Layoff News & Stock Timing and Entry Methods - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is Cullinan Therapeutics Inc. stock ready for a breakout2025 Historical Comparison & Fast Gain Stock Trading Tips - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is Cullinan Therapeutics Inc. stock poised for growthMarket Weekly Review & Safe Entry Momentum Tips - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Published on: 2025-08-31 01:54:17 - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Cullinan Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Published on: 2025-08-30 20:25:19 - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Fibonacci Retracement Aligns with Support in Cullinan Therapeutics Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스

Aug 30, 2025
pulisher
Aug 30, 2025

How to build a custom watchlist for Cullinan Therapeutics Inc.Dividend Hike & Consistent Income Trade Ideas - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Can Cullinan Therapeutics Inc. ride the EV waveMarket Sentiment Summary & Consistent Profit Trading Strategies - sundaytimes.kr

Aug 30, 2025

Cullinan Therapeutics Inc Azioni (CGEM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Cullinan Therapeutics Inc Azioni (CGEM) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
AHMED NADIM
President and CEO
Feb 25 '25
Sale
8.53
12,529
106,872
430,621
Michaelson Jennifer
Chief Scientific Officer
Feb 25 '25
Sale
8.53
3,756
32,039
142,004
SUMER JACQUELYN L
Chief Legal Officer
Feb 25 '25
Sale
8.53
3,756
32,039
136,895
Michaelson Jennifer
Chief Scientific Officer
Jan 06 '25
Sale
12.51
4,000
50,040
95,760
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Capitalizzazione:     |  Volume (24 ore):